Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 334 results for "cadila health"

Zydus gets tentative nod from USFDA to market diabetic tablets
India TV

Zydus gets tentative nod from USFDA to market diabetic tablets

PTI [ Updated 16 Sep 2014, 16:07:55 ] New Delhi: Drug firm Zydus Cadila has received a tentative nod from the health regulator USFDA to market Glipizide tablets, used for treatment of diabetes, in America. "Zydus Cadila has received tentative ... India TV, 2 weeks ago
Zydus gets USFDA tentative nod for diabetic tablets Press Trust of India, 2 weeks ago

3 images for "cadila health"

India TV, 1 week ago
Business Today India, 1 week ago
Money Control, 1 month ago
Business Standard India

Gilead Licenses Hepatitis Therapy in India Amid Price Criticism

Gilead Sciences Inc. The agreements allow Cadila Healthcare Ltd. (CDH), Cipla Ltd., Hetero Labs Ltd., Mylan Laboratories Ltd. The drug's pricing has drawn criticism from pharmacy benefit managers, as well as questions from U.S. Senators Charles ...
 BusinessWeek2 weeks ago Gilead inks licensing pacts for Hep C drug with Ranbaxy, Cipla, Mylan, four Indian firms  Business Standard India1 week ago Generic drugs help US save $239 bn in healthcare spend in 2013  Livemint.com1 week ago Gilead Inks Generic Licensing Pacts to Increase Access to Hepatitis C Treatments in Developing Countries [Health & Beauty Close - Up]  Pharmacy Choice1 week ago
Business Standard

Zydus Cadila gets USFDA nod for kidney stones tablets

Drug firm Zydus Cadila has received the final approval from the US health regulator to market Potassium Citrate ER tablets used in prevention of kidney stones. Zydus Cadila has received the final approval from the United States Food and Drug Administration ...
 Business Standard1 month ago Zydus Cadila Gets US Regulatory Nod for Kidney Stone Tablets  NDTV Profit1 month ago Zydus Cadila gets US FDA nod to market kidney stone tablets  Livemint.com1 month ago Zydus Cadila gets United States Food and Drug Administration nod for kidney stones tablets  Economic Times1 month ago
Business Standard India

Cadila Healthcare: Updates on outcome of AGM

Cadila Healthcare Ltd has submitted to BSE a copy of proceedings of the 19th Annual General Meeting of the members of the Company held on July 30, 2014.Source : BSE Read all announcements in Cadila Health To read the full report
 Moneycontrol.com1 month ago Cadila's Moraiya facility under US FDA lens  Business Standard India2 months ago USFDA raises a red flag for Cadila's ANDA application  Business Standard India1 month ago FDA raises concern over drug production process at India's Cadila  Reuters2 months ago

Focus on stocks, says Dipan Mehta; picks top 5 phama bets

D On specific stocks, he is betting on pharma stocks and likes Ajanta Pharma , IPCA Labs , Cadila Health , Torrent Pharma and Alembic Pharma . From the FMCG space, he is cautious on cigarette major ITC on the back of tobacco business-related ...
 Moneycontrol.com1 month ago Pharma stocks outperform equity benchmarks, rally 2-14%  Moneycontrol.com1 month ago Pharmexcil to celebrate 10 years of success on Sept 18 & 19 in Hyderabad  PharmaBiz2 weeks ago

Cadila Health at new high on USFDA nod for anti-viral drug

Zydus Cadila has received the final approval from the USFDA to market Acyclovir tablets in the strenths of 400 mg and 800 mg.
 Money Control1 month ago

Bull's Eye: India Cements, IRB Infra, Cadila Health, SKS

Vishal Malkan, advises buying India Cements for a target price of Rs 110 and Adani Enterprises for a target price of Rs 450.
 Money Control2 months ago Buy Hathway Cable, Cadila Health, Wockhardt: AK Prabharkar  Money Control2 months ago

Neutral on Cadila Health, target Rs 1,180: Espirito Santo

Summary We remain neutral on Cadila Healthcare (CDH) due to lopsided growth, but revise our target price to R1,180 (earlier R910) as we roll our valuations forward to July 2015. We value Cadila using our standard three-stage DCF model with five-year ...
 Financial Express1 month ago Cadila Health up 2.5%, Credit Suisse maintains outperform  Money Control2 months ago

Cadila Health Q1 profit up 23% to Rs 240 cr led by US sales

Consolidated revenue jumped 25.2 percent to Rs 2,050 crore in the quarter ended June 2014 from Rs 1,637 crore in same quarter last year. "Sales growth was buoyed by formulations business in the US, which grew by 88 percent during the quarter," said the ...
 Money Control2 months ago

Buy Cadila Health, Berger Paints, Jyothy Labs: Paras Bothra

Paras Bothra of Ashika Stock Broking recommends buying Berger Paints with a target of Rs 320 and Jyothy Laboratories.
 Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less